FDA Expands Use of Abbott's Humira
14th Nov 2006, 15:40 GMT
Health care products company Abbott Labs said the FDA expanded approval of its rheumatoid arthritis drug Humira to treat psoriatic arthritis conditions.
FDA Expands Use of Abbott's Humira related news:
- Abbott's Humira Positive in 2 Studies — Operations-Related News from StratCenter.com
- Abbott's Humira gets expanded indication — United Press International - Health Business
- Abbott's HUMIRA Receives FDA Approval for Inhibiting Structural Joint Damage and Improving Physical Function in Patients With Psoriatic Arthritis — Government/ Industry Regulation News from StratCenter.com
- Abbott Begins Kos Tender Offer — Financial News News from StratCenter.com
- ACR: Humira Shows 'Profound' Benefit for Kids With Rheumatoid Arthritis — MedPage Today Pediatrics
- Abbott Labs Commences Tender Offer for All Outstanding Shares of Kos Pharmaceuticals — StratWire - Business of Healthcare NewsFeed
- FDA should return to 'science-based' agency — News-Medical News Feed
- Drug Safety Reform and Risk Management Plans - A Test Case? Senior FDA Policymakers and Experts to Answer Urgent Questions at Windhover's FDA/CMS Summit Dec 4-5, Washington, DC — RedOrbit News - Health
- Dendreon Asks FDA to OK Prostate Drug — Government/ Industry Regulation News from StratCenter.com
- North American Scientific Announces FDA Clearance of its ClearPath HDR Breast Brachytherapy System — FDA News News from StratCenter.com
Latest news from Government/ Industry Regulation News from StratCenter.com:
- PLC Systems to Show RenalGuard at Medica 2006
- National Public Health Summit Targets Cervical Cancer Elimination
- MediPurpose Announces Exclusive Distribution Agreement for Sangofer Blood Separation Product
- Portrait PSR3 by Rhytec named in TIME Magazine's 2006 Skin Technology Story
- Pharsight Invited to Present on Model-Based Drug Development rd Annual Australian Health and Medical Research Congress
- Spectrum Pharmaceuticals Announces Presentation of Ozarelix Data at the Congress of the Societe Internationale d'Urologie
- Newly FDA Approved SmartLipo Laser Liposuction Available at the Intimate Rejuvenation and Innovative Surgery Center, Phoenix, AZ
- Sector Election Boosts Stem Cells
- AUDIO From Medialink and AARP: Voters' Call for Change Signals New Directions for Health Care
- Schering-Plough CEO Calls on New Congress to 'Do What Is Right' for the Patient, Calls for 'Scorecards' to Rate Managed Care Performance